Sign in
Join
Help
VetSurgeon.
org
Home
News
Discussions
Jobs
Films
Films
All films
Veterinary Controversies
Veterinary Costs
Talking Points
Product Briefings
Cardiology
Dentistry
Dermatology
Diagnostic Imaging
Equine
Exotics
Farm Animal
Neurology
Ophthalmology
Orthopaedics
Pathology/Cytology
Soft Tissue Surgery
Menu
VETERINARY NEWS
Topic: The University of Liverpool Small Animal Teaching Hospital
← Back to all news
Sort by:
Most Recent
|
Most Views
|
Most Comments
Posted
15 Jan 2008, 0 Comment(s)
New antibiotic may point to impact of poor compliance in practice
Published By
Arlo Guthrie
VetSurgeon News
https://www.vetsurgeon.org/cfs-file.ashx/__key/communityserver-components-sitefiles/graphics-logos/vetsurgeon_2D00_news.gif
Dr Tim Nuttall, Senior Lecturer in Dermatology at The University of Liverpool Small Animal Teaching Hospital reports as good or better results when treating skin infections in cats and dogs with
Pfizer's Convenia (cefovecin)
than with clavulanate-potentiated amoxicillin and cefalexin.
He said: “What we don’t know is whether this efficacy is associated with Convenia’s protein binding and particularly good penetration into sites of inflammation, or whether it is because the antibiotic is administered by injection every 2 weeks, so we have 100% compliance.
"In fact, it's probably a combination of the two. Nevertheless, it may still be a glimpse of the impact of compliance issues, and an indication of just what we can achieve with 100% compliance".
Dr Tim Nuttall, Senior Lecturer in Dermatology at The University of Liverpool Small Animal Teaching Hospital reports as good or better results when treating skin infections in cats and dogs with Pfizer's Convenia (cefovecin) than with clavulanate...
Claim CPD
Add the time spent on this item to my VetSurgeon.org Personal Development Record
Time Spent (minutes)
What I learned?
How will I put what I learned into practice?
Submit